Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 2 087.6499 INR -1.24%
Market Cap: 158.7B INR
Have any thoughts about
Caplin Point Laboratories Ltd?
Write Note

Caplin Point Laboratories Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Caplin Point Laboratories Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Cash from Investing Activities
-â‚ą3B
CAGR 3-Years
-81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Investing Activities
-â‚ą40.3B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Investing Activities
-â‚ą29.6B
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Investing Activities
-â‚ą42.7B
CAGR 3-Years
-110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Investing Activities
-â‚ą1.6B
CAGR 3-Years
-262%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Investing Activities
-â‚ą20.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Caplin Point Laboratories Ltd
Glance View

Market Cap
158.7B INR
Industry
Pharmaceuticals

Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Chennai, Tamil Nadu. The firm is producing, developing and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals, and sachets (liquids and powders). The company also manufactures a range of ointments, creams, gels and lotions. The Company’s principal research and development facilities are located in Tamil Nadu, India. Its principal manufacturing facility is located in Puducherry, India. The Company’s subsidiaries include Caplin Point Far East Limited, Caplin Point (S) PTE Ltd, Caplin Steriles Limited and Caplin Point Laboratories Colombia SAS.

CAPLIPOINT Intrinsic Value
1 144.9378 INR
Overvaluation 45%
Intrinsic Value
Price

See Also

What is Caplin Point Laboratories Ltd's Cash from Investing Activities?
Cash from Investing Activities
-3B INR

Based on the financial report for Sep 30, 2024, Caplin Point Laboratories Ltd's Cash from Investing Activities amounts to -3B INR.

What is Caplin Point Laboratories Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-81%

Over the last year, the Cash from Investing Activities growth was -1%. The average annual Cash from Investing Activities growth rates for Caplin Point Laboratories Ltd have been -81% over the past three years .

Back to Top